1. AASLD/IDSA, Recommendations for testing, managing, and treating hepatitis C. Infectious Diseases Society of America/American Association for the Study of the Liver. Available at: http://www.hcvguidelines.org Accessed May 10, (2017).
2. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection;Afdhal;The New England Journal of Medicine,2014
3. Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial;Akiyama;Annals of Internal Medicine,2019
4. Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents;Alavi;Liver International,2014
5. Alderks, C.(2017).Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003-2015 (Update). Available at: https://www.samhsa.gov/data/sites/default/files/report_3192/ShortReport-3192.html Accessed March 15th.